Ras inhibitors
US-2025051306-A1 · Feb 13, 2025 · US
This page is not indexed by search engines while we improve data quality.
Thomas William D patents
Thomas William D is listed as an inventor on 21 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Thomas William D |
| Total patents | 21 |
| First publication | Jan 15, 2015 |
| Latest publication | Feb 13, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
US-10745364-B2 · Aug 18, 2020 · US
Inhibitors of brutons tyrosine kinase
US-2020079754-A1 · Mar 12, 2020 · US
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
US-2019292159-A1 · Sep 26, 2019 · US
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
US-10377768-B2 · Aug 13, 2019 · US
Inhibitors of bruton's tyrosine kinase
US-2019100505-A1 · Apr 4, 2019 · US
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
US-10221146-B2 · Mar 5, 2019 · US
Inhibitors of bruton's tyrosine kinase
US-2018030027-A1 · Feb 1, 2018 · US
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
US-2018030005-A1 · Feb 1, 2018 · US
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
US-9809561-B2 · Nov 7, 2017 · US
Recent patents
Latest publications not already listed above.
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
US-2017313722-A1 · Nov 2, 2017 · US
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9657033-B2 · May 23, 2017 · US
Inhibitors of Bruton's tyrosine kinase
US-9656988-B2 · May 23, 2017 · US
Inhibitors of bruton's tyrosine kinase
US-2016355498-A1 · Dec 8, 2016 · US
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
US-2016304476-A1 · Oct 20, 2016 · US
N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides
US-9409909-B2 · Aug 9, 2016 · US
Inhibitors of Bruton's tyrosine kinase
US-9382246-B2 · Jul 5, 2016 · US
Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease
US-9266827-B2 · Feb 23, 2016 · US
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
US-2015111877-A1 · Apr 23, 2015 · US
N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
US-2015018337-A1 · Jan 15, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Lycera Corp | 12 |
| Merck Sharp & Dohme | 11 |
| Pharmacyclics Llc | 6 |
| Chemocentryx Inc | 2 |
| Glick Gary D | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D471/04 | 20 |
| C07D401/12 | 14 |
| C07D413/14 | 14 |
| A61P43/00 | 14 |
| A61P37/00 | 14 |